Showing 1 - 10 of 16
Oped, Postbag, Published on 20/08/2021
» Re: "Why more Sinovac?," (Editorial, Aug 18).
News, Nattaya Chetchotiros, Published on 16/07/2021
» AstraZeneca has asked Thailand to extend the timeline for the delivery of 61 million doses of its Covid-19 vaccine until May next year, Deputy Public Health Minister Sathit Pitutecha said.
News, Published on 15/07/2021
» The Government Pharmaceutical Organisation (GPO) has filed complaints with police accusing Thonburi Healthcare Group chairman Boon Vanasin and a mathematician of defamation.
Gary Boyle, Published on 14/07/2021
» Hospitals and health offices are confused over the mixing of doses of Sinovac and AstraZeneca vaccines after the Health Ministry's latest policy announcement.
Gary Boyle, Published on 05/07/2021
» The government has been criticised over the slow rollout of AstraZeneca vaccines, leading to vaccination schedules being postponed.
Oped, Postbag, Published on 10/06/2021
» Re: "Disparity worsens ocean pollution," (Opinion, June 9).
News, Post Reporters, Published on 04/06/2021
» A website for Covid-19 vaccination registration in Chiang Mai opened for foreigners on Thursday, while vaccinations for migrant workers has kicked off in Phuket.
Gary Boyle, Published on 03/06/2021
» The government has said that foreign nationals living in the kingdom who have registered for vaccination will start receiving the Covid-19 vaccine from next Monday.
News, Veera Prateepchaikul, Published on 31/05/2021
» Despite reassurances from Prime Minister Prayut Chan-o-cha and Public Health Minister Anutin Charnvirakul that the mass Covid-19 vaccinations for people over 60 and those suffering from seven non-communicable underlying diseases across the country will proceed as scheduled on June 7, scepticism remains strong among many about whether this administration can still be trusted after repeated blunders in the handling of the pandemic.
Online Reporters, Published on 09/05/2021
» Samples from test batches of the Covid-19 vaccine made by Siam Bioscience have passed quality testing at AstraZeneca's designated laboratories in Europe and the United States, the company announced on Sunday.